Last reviewed · How we verify
NCT06904469
Ostrobothnia Digital Clinic Experiment
NA trial testing Access to a digital clinic in Primary Care Provider in 170,306 participants. Participants enrolled and being followed up; not accepting new ones.
14 January 2026
Quick facts
| Lead sponsor | Finnish Institute for Health and Welfare |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 170,306 |
| Start date | 15 April 2025 |
| Primary completion | 14 January 2026 |
| Estimated completion | 14 January 2026 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Access to a digital clinic
Conditions studied
- Primary Care Provider — all drugs for Primary Care Provider →
Sponsor
Finnish Institute for Health and Welfare
Who can join
Eligibility, any sex, with Primary Care Provider. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial (RCT) examines the impacts of a publicly provided digital clinic that offers digital primary care services to consumers. This intervention grants access to a public digital clinic that provides chat-based primary care consultations via a mobile phone application and website, including care needs assessment, diagnoses, follow-up care recommendations, and prescriptions. The digital clinic supplements traditional public primary care services, including in-person visits and phone consultations. The trial takes place in Ostrobothnia, Finland, a healthcare district serving a population of 178,000 residents. The investigators will randomize access to the digital clinic at the household level, providing access to 50% of the households. By doing so, the investigators aim to evaluate whether digital services can substitute for, complement, or increase the utilization of traditional primary care, particularly in-person visits or calls to traditional clinics. At the end of the nine-month trial, access to the digital clinic will be expanded to the entire population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06904469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Finnish Institute for Health and Welfare trials
Trials by the same sponsor.
- NCT05565170 — Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults · NA · active not recruiting
- NCT05117333 — Reminders, Cost Sharing, and Healthcare Use · NA · completed
- NCT03332966 — Youth Experiences and Health Study · recruiting
- NCT03748160 — Herd Immunity and Influenza Vaccine Uptake · NA · completed
- NCT03430180 — Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06904469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Finnish Institute for Health and Welfare
- Last refreshed: 20 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06904469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing